|
|
||||||||
The Journal of Immunology, Vol 159, Issue 2 554-564, Copyright © 1997 by American Association of Immunologists
ARTICLES |
A Vinitsky, LC Anton, HL Snyder, M Orlowski, JR Bennink and JW Yewdell
Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, NY 10029, USA.
The proteasome is believed to participate in the generation of a large percentage of peptide ligands for MHC class I molecules. This conclusion is based largely on the activities of peptidyl aldehydes that block proteasome activity. We tested the ability of a panel of proteasome inhibitors to affect the generation of MHC class I binding peptides in mouse L929 cells. Included in the panel are peptidyl aldehydes and a microbial product, lactacystin, that blocks proteasome activity in a distinct and more specific manner. Contrary to expectations, proteasome inhibitors failed to block the generation of a large portion of high affinity peptides as inferred by measuring cell surface expression of newly synthesized MHC class I molecules. These findings were confirmed by examining the effects of the inhibitors on the presentation of individual antigenic determinants from endogenously synthesized or exogenously delivered influenza virus proteins. Presentation of peptides derived from exogenous basic polymerase 1, endogenous basic polymerase 1, and nonstructural-1 proteins was decreased by inhibitors in a manner consistent with proteasomal involvement. Presentation of peptides derived from endogenous nucleoprotein was not significantly affected by the proteasome inhibitors, while presentation of exogenous hemagglutinin and nucleoprotein was enhanced by the proteasome inhibitors. These data are consistent with the involvement of both proteasomes and nonproteasomal cytosolic proteases in the generation of a significant portion of MHC class I binding peptides.
This article has been cited by other articles:
![]() |
M. Marcilla, J. J. Cragnolini, and J. A. Lopez de Castro Proteasome-independent HLA-B27 Ligands Arise Mainly from Small Basic Proteins Mol. Cell. Proteomics, May 1, 2007; 6(5): 923 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Wherry, T. N. Golovina, S. E. Morrison, G. Sinnathamby, M. J. McElhaugh, D. C. Shockey, and L. C. Eisenlohr Re-evaluating the Generation of a "Proteasome-Independent" MHC Class I-Restricted CD8 T Cell Epitope J. Immunol., February 15, 2006; 176(4): 2249 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. SenGupta, P. J. Norris, T. J. Suscovich, M. Hassan-Zahraee, H. F. Moffett, A. Trocha, R. Draenert, P. J. R. Goulder, R. J. Binder, D. L. Levey, et al. Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II J. Immunol., August 1, 2004; 173(3): 1987 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Bland, M. K. Lemberg, A. J. McMichael, B. Martoglio, and V. M. Braud Requirement of the Proteasome for the Trimming of Signal Peptide-derived Epitopes Presented by the Nonclassical Major Histocompatibility Complex Class I Molecule HLA-E J. Biol. Chem., September 5, 2003; 278(36): 33747 - 33752. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Admon, E. Barnea, and T. Ziv Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides Mol. Cell. Proteomics, June 1, 2003; 2(6): 388 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Golovina, E. J. Wherry, T. N. J. Bullock, and L. C. Eisenlohr Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum J. Immunol., March 15, 2002; 168(6): 2667 - 2675. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lomas, E. Hanon, Y. Tanaka, C. R. M. Bangham, and K. G. Gould Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin J. Gen. Virol., March 1, 2002; 83(3): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ota, T. Ono, A. Morita, A. Uenaka, M. Harada, and E. Nakayama Cellular Processing of a Multibranched Lysine Core with Tumor Antigen Peptides and Presentation of Peptide Epitopes Recognized by Cytotoxic T Lymphocytes on Antigen-presenting Cells Cancer Res., March 1, 2002; 62(5): 1471 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lankat-Buttgereit and R. Tampe The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases Physiol Rev, January 1, 2002; 82(1): 187 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Luckey, J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors J. Immunol., August 1, 2001; 167(3): 1212 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yewdell, U Schubert, and J. Bennink At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules J. Cell Sci., January 3, 2001; 114(5): 845 - 851. [Abstract] [PDF] |
||||
![]() |
A. Bai, C. J. Aldrich, and J. Forman Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1 J. Immunol., December 15, 2000; 165(12): 7025 - 7034. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schwarz, R. de Giuli, G. Schmidtke, S. Kostka, M. van den Broek, K. B. Kim, C. M. Crews, R. Kraft, and M. Groettrup The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses J. Immunol., June 15, 2000; 164(12): 6147 - 6157. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lopez, B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation J. Immunol., May 15, 2000; 164(10): 5070 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Lich, J. F. Elliott, and J. S. Blum Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins J. Exp. Med., May 1, 2000; 191(9): 1513 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.A.M. Sijts, T. Ruppert, B. Rehermann, M. Schmidt, U. Koszinowski, and P.-M. Kloetzel Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes J. Exp. Med., February 7, 2000; 191(3): 503 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Y. Mo, P. Cascio, K. Lemerise, A. L. Goldberg, and K. Rock Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides J. Immunol., December 1, 1999; 163(11): 5851 - 5859. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Gileadi, H. T. Moins-Teisserenc, I. Correa, B. L. Booth Jr., P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo Generation of an Immunodominant CTL Epitope Is Affected by Proteasome Subunit Composition and Stability of the Antigenic Protein J. Immunol., December 1, 1999; 163(11): 6045 - 6052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. McPherson, J. P. Roberts, and D. S. Gregerson Systemic Expression of Rat Soluble Retinal Antigen Induces Resistance to Experimental Autoimmune Uveoretinitis J. Immunol., October 15, 1999; 163(8): 4269 - 4276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sewell, D. A. Price, H. Teisserenc, B. L. Booth Jr., U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo IFN-{gamma} Exposes a Cryptic Cytotoxic T Lymphocyte Epitope in HIV-1 Reverse Transcriptase J. Immunol., June 15, 1999; 162(12): 7075 - 7079. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Serwold and N. Shastri Specific Proteolytic Cleavages Limit the Diversity of the Pool of Peptides Available to MHC Class I Molecules in Living Cells J. Immunol., April 15, 1999; 162(8): 4712 - 4719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Valmori, U. Gileadi, C. Servis, P. R. Dunbar, J.-C. Cerottini, P. Romero, V. Cerundolo, and F. Levy Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte-defined Peptide Derived from the Tumor Antigen MAGE-3 J. Exp. Med., March 15, 1999; 189(6): 895 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mylin Context-Dependent Immunogenicity of an S206G-Substituted H-2Db-Restricted Simian Virus 40 Large T Antigen Epitope I Variant J. Immunol., February 15, 1999; 162(4): 2171 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Carbonetti, T. J. Irish, C. H. Chen, C. B. O'Connell, G. A. Hadley, U. McNamara, R. G. Tuskan, and G. K. Lewis Intracellular Delivery of a Cytolytic T-Lymphocyte Epitope Peptide by Pertussis Toxin to Major Histocompatibility Complex Class I without Involvement of the Cytosolic Class I Antigen Processing Pathway Infect. Immun., February 1, 1999; 67(2): 602 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Deng, J. Gibbs, I. Bacik, A. Porgador, J. Copeman, P. Lehner, B. Ortmann, P. Cresswell, J. R. Bennink, and J. W. Yewdell Assembly of MHC Class I Molecules with Biosynthesized Endoplasmic Reticulum-Targeted Peptides Is Inefficient in Insect Cells and Can Be Enhanced by Protease Inhibitors J. Immunol., August 15, 1998; 161(4): 1677 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Benham, M. Gromme, and J. Neefjes Allelic Differences in the Relationship Between Proteasome Activity and MHC Class I Peptide Loading J. Immunol., July 1, 1998; 161(1): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Luckey, G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol J. Immunol., July 1, 1998; 161(1): 112 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Anton, H. L. Snyder, J. R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J. W. Yewdell Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides J. Immunol., May 15, 1998; 160(10): 4859 - 4868. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Snyder, I. Bacik, J. R. Bennink, G. Kearns, T. W. Behrens, T. Bachi, M. Orlowski, and J. W. Yewdell Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing J. Exp. Med., October 6, 1997; 186(7): 1087 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |